Mirum Pharmaceuticals, Inc.
CTEXLI
cerebrotendinous xanthomatosis (CTX)
Date
TBD
Approval decision · Date TBD estimated
What's at stake
A final FDA approval decision on CTEXLI for cerebrotendinous xanthomatosis (CTX) is expected Date TBD.
Primary source
· SEC 8-K
verified 14h ago
“Received FDA approval of CTEXLI ® for cerebrotendinous xanthomatosis (CTX).”